SinuSonic

SinuSonic is a private, commercial-stage medical device company offering a novel, non-pharmacological solution for nasal congestion. Its handheld device employs a combination of gentle acoustic vibration and positive expiratory pressure (PEP), technologies with a clinical foundation in lower airway therapy, to address upper airway congestion. The company is positioned in the large and growing market for chronic rhinitis and congestion management, competing against drug-based sprays and irrigation systems by emphasizing a safe, hygienic, and side-effect-free profile. SinuSonic sells directly to consumers online and appears to be in an early revenue-generating phase.

A handheld device combining Positive Expiratory Pressure (PEP) and acoustic vibration to naturally open nasal passages and promote sinus drainage without drugs or irrigation.

SinuSonic competes in the broad nasal congestion market dominated by OTC decongestants (e.g., Afrin, Sudafed), corticosteroid sprays (Flonase, Nasacort), antihistamines, and saline irrigation systems (including NeilMed's own Sinus Rinse). Its key differentiation is being a non-pharmacological, reusable device with no risk of rebound congestion or systemic side effects. It also competes with other physical therapy devices like nasal dilators, though few use the PEP-vibration mechanism.